Intravitreal Aflibercept for the Treatment of Diabetic Macular Edema in Routine Clinical Practice: Results from the 24-Month AURIGA Observational Study

Intravitreal Aflibercept for the Treatment of Diabetic Macular Edema in Routine Clinical Practice: Results from the 24-Month AURIGA Observational Study

Abstract Introduction AURIGA is the largest real-world study to date to evaluate intravitreal aflibercept (IVT-AFL) in the treatment of diabetic macular edema (DME) or macular edema secondary to retinal vein occlusion in routine clinical practice. The 24-month outcomes in the DME cohort from across...

Full description

Bibliographic Details
Main Authors: Simone Donati, Chang-Hao Yang, Xun Xu, Marco Mura, Audrey Giocanti-Aurégan, Hans Hoerauf, Helmut Allmeier, Tobias Machewitz, Kristian T. Johnson, Elina Santoro, On behalf of the AURIGA study investigators
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-11-01
Series:Ophthalmology and Therapy
Subjects:
Anti-vascular endothelial growth factor
Diabetes
Diabetic macular edema
Diabetic retinopathy
Intravitreal aflibercept
Observational study
Online Access:https://doi.org/10.1007/s40123-023-00829-3

Internet

https://doi.org/10.1007/s40123-023-00829-3

Similar Items